drugset / Trial / NCT00813670

Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

NCT00813670 ↗

Phase 1 Completed 64 enrolled Xenon Pharmaceuticals Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple doses of XPF-001 in healthy volunteers. The effect of food on the pharmacokinetics of XPF-001 will also be studied.

Timeline

Start
2008-11
Primary completion
2009-05
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject XPF-001 Unknown — Oral

Indications

No indication recorded.